Patent intelligence · US
US 7927833
Composition and method for enhancing immune response
Composition and method for enhancing immune response
Patent details — US 7927833
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 19, 2011
- Expiration
- Apr 14, 2031
- Claims
- 5
- CPC classes
- A61K, A61K2039/541, A61K2039/55516, A61K2039/6037
Quick answer
US 7927833 (Composition and method for enhancing immune response) is held by ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY. Status: granted. Granted Apr 19, 2011. Expires Apr 14, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K2039/541, A61K2039/55516, A61K2039/6037, A61K2039/6075, A61K39/39
More from ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Related pharmaceutical patents in our USPTO index.
-
US 12428463
Chimeric antigen receptors targeting abnormal glycobiology
granted -
US 12427148
Cancer treatment targeted to tumor adaptive responses to protein synthesis stress
granted -
US 12428416
ERK inhibitors and uses thereof
granted -
US 12427151
Compositions and method of treating cancer
granted -
US 12427197
Methods of producing cobalt nanoparticles and hollow metal nanospheres
granted -
US 12428489
Human PD-L2 antibodies and methods of use therefor
granted -
US 12427155
Treatment for tau-related diseases
granted -
US 12428455
Dominant negative CEBPB and CEBPD proteins and methods of use for decreasing viability of neoplastic cells
granted
Frequently asked questions
What is US patent 7927833?
US 7927833 (Composition and method for enhancing immune response) is held by ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY. Status: granted. Granted Apr 19, 2011. Expires Apr 14, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7927833?
ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8,292 pharmaceutical patents for this assignee.
When does US 7927833 expire?
Our index shows an expiration date of Apr 14, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.